New Chinese original Alzheimer’s disease approved, new hope for Alzheimer’s disease
Authorities in China have approved a drug for the treatment of Alzheimer’s disease, the first new medicine with the potential to treat the cognitive disorder in 17 years. 中国有关部门已批准一种治疗阿尔茨海默症的药物，这是17年来首个可能对这种认知障碍有治疗效果的新药。 The seaweed-based drug, called Oligomannate, can be used for the treatment of mild to moderate Alzheimer’s, according to a statement from China’s drug safety agency. 中国药品安全监督管理局发表的一份声明显示，这个被称为甘露特钠胶囊的海藻类药物可以用于治疗轻度至中度的阿尔茨海默症。…
Details
